The Glycotope-Specific RAV12 Monoclonal Antibody Induces Oncosis in Vitro and Has Antitumor Activity Against Gastrointestinal Adenocarcinoma Tumor Xenografts in Vivo
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0581
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)